Improving Representation in Clinical Trials and Research Building Research Equity for Women and Underrepresented Groups
The United States has long made substantial investments in clinical research with the goal of improving the health and well-being of our nation. There is no doubt that these investments have contributed significantly to treating and preventing disease and extending human life. Nevertheless, clinical...
Autores Corporativos: | , , , , |
---|---|
Otros Autores: | , , , |
Formato: | Libro electrónico |
Idioma: | Inglés |
Publicado: |
Washington, D.C. :
National Academies Press
2023.
|
Materias: | |
Ver en Biblioteca Universitat Ramon Llull: | https://discovery.url.edu/permalink/34CSUC_URL/1im36ta/alma991009719839506719 |
Tabla de Contenidos:
- Intro
- FrontMatter
- Acknowledgments
- Preface
- Contents
- Boxes, Figures, and Tables
- Summary
- 1 The Committee's Task
- 2 Why Diverse Representation in Clinical Research Matters and the Current State of Representation within the Clinical Research Ecosystem
- 3 Policies to Improve Clinical Trial and Research Diversity: History and Future Directions
- 4 Barriers to Representation of Underrepresented and Excluded Populations in Clinical Research
- 5 Facilitators of Successful Inclusion in Clinical Research
- 6 Recommendations for Improving Representation in Clinical Trials and Clinical Research
- Epilogue: Envisioning a New Future
- References
- Appendix A: Quantifying the Potential Health and Economic Impacts of Increased Trial Diversity
- Appendix B: Key Trends in Demographic Diversity in Clinical Trials
- Appendix C: Improving Representativeness in Clinical Trials and Research: Facilitators to Recruitment and Retention of Underrepresented Groups.